Cited by 821Cardiac electrophysiology and arrhythmiasAcute Myocardial Infarction ResearchCardiac pacing and defibrillation studies

The DOI matches its Crossref record, with a small difference in title or year; 116 of the 116 references it cites were found in a registry or an index.

Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

Open access

Drew, Barbara J., Ackerman, Michael J., Funk, Marjorie, Gibler, W. Brian, Kligfield, Paul, Menon, Venu, Philippides, George J., Roden, Dan M., Zareba, Wojciech·2010·Circulation

DOI 10.1161/circulationaha.109.192704PMC PMC3056123

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.192704

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Self-citation
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Self-citation
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353
Approaches to Sudden Death from Coronary Heart Disease
Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Flagged first, then by citations

Show all 115 references

Research works printed but not linked: 8

Dessertenne F. La tachycardie ventriculaire á deux foyers opposes variables. Arch Mal Coeur Vaiss. 1966; 59: 263–272.
10.1161/circ.105.10.1247 · DOI
10.1161/circ.96.12.4392 · DOI
10.1161/circ.97.5.493 · DOI
10.1161/res.55.3.6088114 · DOI
10.1001/jama.1993.03510210076031 · DOI
10.1161/circ.96.7.2149 · DOI
10.1097/01.AACN.0000284429.45534.4a · DOI

Sorted by citations

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
Authors Task Force Members, Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. D., Ford, I., González‐Juanatey, J. R., Görenek, B., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,687
Magnesium in Prevention and Therapy
Gröber, U., Schmidt, J., & Kisters, K. (2015) · Nutrients · doi:10.3390/nu7095388 · Cited by 1,061
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Herrmann, J., Lenihan, D. J., Armenian, S. H., Barac, A., Blaes, A. H., Cardinale, D. M., Carver, J. R., Dent, S. F., Ky, B., Lyon, A. R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab674 · Cited by 699
Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency
Fiorentini, D., Cappadone, C., Farruggia, G., & Prata, C. (2021) · Nutrients · doi:10.3390/nu13041136 · Cited by 626
Drugs That May Cause or Exacerbate Heart Failure
Page, R. L., II, O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. M. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 495
Insights into the Problem of Alarm Fatigue with Physiologic Monitor Devices: A Comprehensive Observational Study of Consecutive Intensive Care Unit Patients
Drew, B. J., Harris, P., Zègre-Hemsey, J. K., Mammone, T., Schindler, D., Salas-Boni, R., Bai, Y., Tinoco, A., Ding, Q., & Hu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110274 · Cited by 438
Self-citation
Untitled work
Verrier (2011) · doi:10.1016/j.jacc.2011.06.029 · Cited by 421
Which QT Correction Formulae to Use for QT Monitoring?
Vandenberk, B., Vandael, E., Robyns, T., Vandenberghe, J. U., Garweg, C., Foulon, V., Ector, J., & Willems, R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003264 · Cited by 428
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Tisdale, J. E., Chung, M. K., Campbell, K. B., Hammadah, M., Joglar, J. A., Leclerc, J., & Rajagopalan, B. (2020) · Circulation · doi:10.1161/cir.0000000000000905 · Cited by 411
2014 ESC/ESA Guidelines on non-cardiac surgery
Kristensen, S. D., Knuuti, J. M., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. G. D., Ford, I., González‐Juanatey, J. R., Görenek, B., Heyndrickx, G. R., et al. (2014) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000150 · Cited by 411
Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Mourad, N. A., Trujillo, T. N., Overholser, B. R., & Kovacs, R. J. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000152 · Cited by 391
Magnesium in Aging, Health and Diseases
Barbagallo, M., Veronese, N., & Dominguez, L. J. (2021) · Nutrients · doi:10.3390/nu13020463 · Cited by 394
Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association
Sandau, K. E., Funk, M., Auerbach, A. D., Barsness, G. W., Blum, K., Cvach, M. M., Lampert, R., May, J. L., McDaniel, G. M., Perez, M. V., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000527 · Cited by 370
Self-citation
Predicting the Unpredictable
Schwartz, P. J., & Woosley, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.063 · Cited by 329
Drug-induced QT interval prolongation: mechanisms and clinical management
Nachimuthu, S., Assar, M. D., & SCHUSSLER, J. M. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612454283 · Cited by 325
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
Chorin, E., Wadhwani, L., Magnani, S., Dai, M. S., Shulman, E. H., Nadeau‐Routhier, C., Knotts, R. J., Bar-Cohen, R., Kogan, E., Barbhaiya, C. R., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.014 · Cited by 298
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
Alexandre, J., Cautela, J., Éderhy, S., Damaj, G. L., Salem, J., Barlési, F., Farnault, L., Charbonnier, A., Mirabel, M., Champiat, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018403 · Cited by 303
Cardiovascular Complications of Cancer Therapy
Chang, H., Okwuosa, T. M., Scarabelli, T. M., Moudgil, R., & Yeh, E. T. H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1095 · Cited by 296
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium
Krishna, K. B., Fuqua, J. S., Rogol, A. D., Klein, K. O., Popovic, J., Houk, C. P., Charmandari, E., & Lee, P. A. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501336 · Cited by 291
The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias
Curtis, M. J., Hancox, J. C., Farkas, A., Wainwright, C. L., Stables, C. L., Saint, D. A., Clements‐Jewery, H., Lambiase, P. D., Billman, G. E., Janse, M. J., et al. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.008 · Cited by 293
Self-citation
Cardiovascular complications of anorexia nervosa: A systematic review
Sachs, K. V., Harnke, B., Mehler, P. S., & Krantz, M. J. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22481 · Cited by 273
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Bessière, F., Roccia, H., Delinière, A., Charrière, R., Chevalier, P., Argaud, L., & Cour, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1787 · Cited by 271
Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society
Chou, R., Cruciani, R. A., Fiellin, D. A., Compton, P. A., Farrar, J. T., Haigney, M. C., Inturrisi, C. E., Knight, J. R., Otis‐Green, S., Marcus, S. M., et al. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.494 · Cited by 263
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
Trinkley, K. E., Page, R. L., II, Lien, H., Yamanouye, K., & Tisdale, J. E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.840568 · Cited by 231
Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Dan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 247
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
Porta‐Sánchez, A., Gilbert, C. J., SPEARS, D. A., Amir, E., Chan, J., Nanthakumar, K., & Thavendiranathan, P. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007724 · Cited by 233
Risk factors for QTc-prolongation: systematic review of the evidence
Vandael, E., Vandenberk, B., Vandenberghe, J. U., Willems, R., & Foulon, V. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0414-2 · Cited by 215
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management
Tisdale, J. E. (2016) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163516641136 · Cited by 209
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Jankelson, L., Karam, G., Becker, M. L., Chinitz, L. A., & Tsai, M. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.008 · Cited by 188
Long QT Syndrome: An Emerging Role for Inflammation and Immunity
Lazzerini, P. E., Capecchi, P. L., & Pasini, F. L. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00026 · Cited by 173
Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality
Haugaa, K. H., Bos, J. M., Tarrell, R. F., Morlan, B. W., Caraballo, P. J., & Ackerman, M. J. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.013 · Cited by 166
Self-citation
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Palo, K. E. D., Okwuosa, T. M., Przespolewski, E. R., & Sj, D. (2022) · Circulation · doi:10.1161/cir.0000000000001056 · Cited by 170
Pharmacological treatment of acquired QT prolongation and torsades de pointes
Thomas, S. H. L., & Behr, E. R. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12726 · Cited by 161
Novel deep learning model for more accurate prediction of drug-drug interaction effects
Lee, G., Park, C., & Ahn, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3013-0 · Cited by 155
AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C., Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd‐Jones, D. M., Mora, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192617 · Cited by 157
Atrial Fibrillation
Michaud, G. F., & Stevenson, W. G. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2023658 · Cited by 156
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
Naksuk, N., Lazar, S., & Peeraphatdit, T. B. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872620922784 · Cited by 147
Electroimmunology and cardiac arrhythmia
Grune, J., Yamazoe, M., & Nahrendorf, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00520-9 · Cited by 161
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
Fradley, M. G., Beckie, T. M., Brown, S.-A. N., Cheng, R. K.-H., Dent, S. F., Nohria, A., Patton, K. K., Singh, J. P., & Olshansky, B. (2021) · Circulation · doi:10.1161/cir.0000000000000986 · Cited by 152
High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality
Pickham, D. M., Helfenbein, E. D., Shinn, J. A., Chan, G. K., Funk, M., Weinacker, A. B., Liu, J., & Drew, B. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232db4a · Cited by 145
Self-citation
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
Pani, A., Lauriola, M., Romandini, A., & Scaglione, F. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106053 · Cited by 136
Magnesium in disease
Geiger, H., & Wanner, C. (2012) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr165 · Cited by 130
The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation
Koenig, X., & Hilber, K. (2015) · Molecules · doi:10.3390/molecules20022208 · Cited by 129
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Giudicessi, J. R., Schram, M. C., Bos, J. M., Galloway, C. D., Shreibati, J. B., Johnson, P. W., Carter, R. E., Disrud, L. W., Kleiman, R., Attia, Z. I., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050231 · Cited by 130
Self-citation
Drug-Induced QT Prolongation And Torsades de Pointes.
Li, M., & Ramos, L. G. (2017) · PubMed Central · Cited by 124
S2k-Leitlinie: Tuberkulose im Erwachsenenalter
Schaberg, T., Bauer, T. T., Brinkmann, F., Diel, R., Feiterna‐Sperling, C., Haas, W., Hartmann, P., Hauer, B., Heyckendorf, J., Lange, C. G., et al. (2017) · Pneumologie · doi:10.1055/s-0043-105954 · Cited by 121
Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
Girardin, F., Gex‐Fabry, M., Berney, P., Shah, D. C., Gaspoz, J., & Dayer, P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060860 · Cited by 119
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes
Lazzerini, P. E., Pasini, F. L., Bertolozzi, I., Morozzi, G., Lorenzini, S., Simpatico, A., Selvi, E., Bacarelli, M. R., Finizola, F., Vanni, F., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-311079 · Cited by 119
Chloroquine-induced QTc prolongation in COVID-19 patients
van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., & van de Garde, E. M. W. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01429-7 · Cited by 118
Fir(e)ing the Rhythm
Lazzerini, P. E., Abbate, A., Boutjdir, M., & Capecchi, P. L. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.004 · Cited by 126
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 123
Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
Lazzerini, P. E., Capecchi, P. L., El‐Sherif, N., Pasini, F. L., & Boutjdir, M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010595 · Cited by 117
Prevention of complications in the cardiac intensive care unit: a scientific statement from the American Heart Association
Fordyce, C. B., Katz, J. N., Alviar, C. L., Arslanian-Engoren, C., Bohula, E. A., Geller, B. J., Hollenberg, S. M., Jentzer, J. C., Sims, D. B., Washam, J. B., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000909 · Cited by 116
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
Klein, H., Goldenberg, I., & Moss, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht167 · Cited by 115
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias
Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Boutjdir, M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.61 · Cited by 115
A systematic review of the cardiotoxicity of methadone.
Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., & Mehrpour, O. (2015) · EXCLI journal · doi:10.17179/excli2015-553 · Cited by 113
Medical findings in 1,026 consecutive adult inpatient–residential eating disordered patients
Mehler, P. S., Blalock, D. V., Walden, K., Kaur, S., McBride, J., Walsh, K., & Watts, J. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22830 · Cited by 109
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol
Al‐Qadheeb, N. S., Skrobik, Y. K., Schumaker, G. L., Pacheco, M., Roberts, R. J., Ruthazer, R., & Devlin, J. W. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001411 · Cited by 107
Psychiatric considerations in the oncology setting
Mehta, R. D., & Roth, A. J. L. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21285 · Cited by 109
Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2013) · Diabetes Care · doi:10.2337/dc13-0701 · Cited by 103
Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12‐Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide
GARABELLI, P., STAVRAKIS, S., ALBERT, M., KOOMSON, E., PARWANI, P., CHOHAN, J., SMITH, L., ALBERT, D., XIE, R., XIE, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12976 · Cited by 98
CredibleMeds.org: What does it offer?
Woosley, R. L., Black, K., Heise, C. W., & Romero, K. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.07.010 · Cited by 99
Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide
Roboz, G. J., Ritchie, E. K., Carlin, R. F., Samuel, M., Gale, L., Provenzano, J. L., Curcio, T. J., Feldman, E. J., & Kligfield, P. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.2913 · Cited by 91
Self-citation
Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients
Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Overholser, B. R., Mourad, N. A., Trujillo, T. N., & Kovacs, R. J. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000651 · Cited by 94
Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
El‐Sherif, N., Turitto, G., & Boutjdir, M. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.8.3 · Cited by 90
Medication Errors in Acute Cardiovascular and Stroke Patients
Michaels, A. D., Spinler, S. A., Leeper, B. “., Ohman, E. M., Alexander, K. P., Newby, L. K., Ay, H., & Gibler, W. B. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4b43e · Cited by 94
Self-citation
Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians
Porta, A. D., Bornstein, K., Coye, A., Montrief, T., Long, B., & Parris, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.07.030 · Cited by 88
Current Perceptions and Practices Surrounding the Recognition and Treatment of Delirium in the Intensive Care Unit: A Survey of 250 Critical Care Pharmacists from Eight States
Devlin, J. W., Bhat, S., Roberts, R. J., & Skrobik, Y. K. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q332 · Cited by 87
Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs
Tisdale, J. E., Wroblewski, H. A., Overholser, B. R., Kingery, J. R., Trujillo, T. N., & Kovacs, R. J. (2012) · Drug Safety · doi:10.2165/11598160-000000000-00000 · Cited by 85
Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs
Kligfield, P., Badilini, F., Denjoy, I., Babaeizadeh, S., Clark, E., de Bie, J., Devine, B., Extramiana, F., Generali, G., Gregg, R. E., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.02.014 · Cited by 85
Self-citation
Acquired long QT syndrome and torsade de pointes
El‐Sherif, N., Turitto, G., & Boutjdir, M. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13296 · Cited by 86
Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome
Prifti, E., Fall, A., Davogustto, G., Pulini, A., Denjoy, I., Funck‐Brentano, C., Khan, Y. W., Durand-Salmon, A., Badilini, F., Wells, Q. S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab588 · Cited by 81
Self-citation
Postoperative QT Interval Prolongation in Patients Undergoing Noncardiac Surgery under General Anesthesia
Nägele, P., Pal, S., Brown, F., Blood, J., Miller, J. P., & Johnston, J. D. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31825e6eb3 · Cited by 84
Cardiac changes in anorexia nervosa
Spaulding-Barclay, M. A., Stern, J. L., & Mehler, P. S. (2016) · Cardiology in the Young · doi:10.1017/s104795111500267x · Cited by 83
Drug-drug interactions contributing to QT prolongation in cardiac intensive care units
Armahizer, M. J., Seybert, A. L., Smithburger, P. L., & Kane‐Gill, S. L. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.10.014 · Cited by 84
Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus
Morgan, N. D., Patel, S. V., & Dvorkina, O. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31829d5e50 · Cited by 80
QT Assessment in Early Drug Development: The Long and the Short of It
Lester, R. M., Paglialunga, S., & Johnson, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061324 · Cited by 80
Cardiac risks associated with antibiotics: azithromycin and levofloxacin
Lu, K., Yuan, J., Li, M., Sutton, S. S., Rao, G., Jacob, S., & Bennett, C. L. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.989210 · Cited by 78
Prolonged corrected QT interval in anti‐Ro/SSA–positive adults with systemic lupus erythematosus
Bourré‐Tessier, J., Clarke, A. E., Huynh, T. T., Bernatsky, S., Joseph, L., Bélisle, P., & Pineau, C. A. (2011) · Arthritis Care & Research · doi:10.1002/acr.20470 · Cited by 78
Development of a risk score for QTc-prolongation: the RISQ-PATH study
Vandael, E., Vandenberk, B., Vandenberghe, J. U., Spriet, I., Willems, R., & Foulon, V. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0446-2 · Cited by 77
Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives
Duan, J., Tao, J., Zhai, M., Li, C., Zhou, N., Lv, J., Wang, L., Lin, L., & Bai, R. (2018) · Oncotarget · doi:10.18632/oncotarget.25008 · Cited by 79
Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression
Lazzerini, P. E., Acampa, M., Laghi-Pasini, F., Bertolozzi, I., Finizola, F., Vanni, F., Natale, M., Bisogno, S., Cevenini, G., Cartocci, A., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008627 · Cited by 74
Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
Page, R. L., II, Hafermann, M. J., Namdar, & Seibold (2011) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s25623 · Cited by 76
Drug-induced arrhythmias
Barnes, B. J., & Hollands, J. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de112a · Cited by 74
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
Poluzzi, E., Raschi, E., Koci, A., Moretti, U., Spina, E., Behr, E. R., Sturkenboom, M., & Ponti, F. D. (2013) · Drug Safety · doi:10.1007/s40264-013-0032-z · Cited by 71
A current understanding of drug-induced QT prolongation and its implications for anticancer therapy
Roden, D. M. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz013 · Cited by 68
Self-citation
The QT Interval
Giudicessi, J. R., Noseworthy, P. A., & Ackerman, M. J. (2019) · Circulation · doi:10.1161/circulationaha.119.039598 · Cited by 67
Self-citation
Ventricular repolarization measures for arrhythmic risk stratification
Monitillo, F. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i1.57 · Cited by 66
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
Meid, A. D., Bighelli, I., Mächler, S., Mikus, G., Carrà, G., Castellazzi, M., Lucii, C., Martinotti, G., Nosè, M., Ostuzzi, G., et al. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317721662 · Cited by 68
Cardiovascular Disease in Women
Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Barnes, T. R. E., Leeson, V. C., Paton, C., Costelloe, C., Simon, J., Kiss, N., Osborn, D., Killaspy, H. T., Craig, T., Lewis, S. W., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20290 · Cited by 65
Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes
Lazzerini, P. E., Yue, Y., Srivastava, U., Fabris, F., Capecchi, P. L., Bertolozzi, I., Bacarelli, M. R., Morozzi, G., Acampa, M., Natale, M., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003419 · Cited by 64
Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit
Naksuk, N., Hu, T. Y., Krittanawong, C., Thongprayoon, C., Sharma, S., Park, J. Y., Rosenbaum, A. N., Gaba, P., Killu, A. M., Sugrue, A. M., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.08.033 · Cited by 64
Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes
Funk, M., Fennie, K., Stephens, K., May, J. L., Winkler, C. G., Drew, B. J., Borman, B., Calcasola, S., Carey, M. G., Currie, L., et al. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003132 · Cited by 64
Self-citation
Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias
Giudicessi, J. R., Ackerman, M. J., & Camilleri, M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13302 · Cited by 66
Self-citation

Authors: Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W.
ORCID: Ackerman, Michael J.
Funk, Marjorie
Menon, Venu
Philippides, George J.
Roden, Dan M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-03-02
Volume: 121
Issue: 8
Pages: 1047-1060
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.109.192704
PMC: PMC3056123
OpenAlex: W2082072065
Cited by: 821
References: 115
Citations by year: 2026: 32 · 2025: 37 · 2024: 49 · 2023: 41 · 2022: 48 · 2021: 81 · 2020: 90 · 2019: 69 · 2018: 51 · 2017: 62 · 2016: 46 · 2015: 39 · 2014: 43 · 2013: 43 · 2012: 38
FWCI: 28.78
Type: journal article
Language: en
Update notices: correction (2010-08-24)
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL081642)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: torsades de pointes, ventricular arrhythmia prevention, hospitalized patients, antiarrhythmic drugs, QT prolongation, drug-induced arrhythmia
MeSH terms: Electrocardiography, Heart Rate, Hospital Units, Humans, Monitoring, Physiologic, Risk Factors, United States, Torsades de Pointes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks